11603 1 ap Search Results


cct5  (Proteintech)
93
Proteintech cct5
Fig. 3 Prognostic value of <t>CCT5</t> in pan-cancer. (A–D) CCT5’s association with OS (A), PFS (B), PFI (C), DFI (D)
Cct5, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/11603+1+ap/CCT5+Antibody/pm40423850-156-12-15
Average 93 stars, based on 1 article reviews
cct5 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 3 Prognostic value of CCT5 in pan-cancer. (A–D) CCT5’s association with OS (A), PFS (B), PFI (C), DFI (D)

Journal: Cancer immunology, immunotherapy : CII

Article Title: Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.

doi: 10.1007/s00262-025-04071-7

Figure Lengend Snippet: Fig. 3 Prognostic value of CCT5 in pan-cancer. (A–D) CCT5’s association with OS (A), PFS (B), PFI (C), DFI (D)

Article Snippet: The sections were then incubated overnight at 4 °C with primary antibodies, CCT5 (11603- 1-AP, Proteintech).

Techniques:

Fig. 4 Gene set enrichment and cell cycle analysis of CCT5 in pan-cancer. (A) GSEA results of CCT5. (B–I) Cell cycle analyses regarding CCT5 in LIHC (B–C), SKCM (D–E), CHOL (F–G) and BRCA (H–I)

Journal: Cancer immunology, immunotherapy : CII

Article Title: Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.

doi: 10.1007/s00262-025-04071-7

Figure Lengend Snippet: Fig. 4 Gene set enrichment and cell cycle analysis of CCT5 in pan-cancer. (A) GSEA results of CCT5. (B–I) Cell cycle analyses regarding CCT5 in LIHC (B–C), SKCM (D–E), CHOL (F–G) and BRCA (H–I)

Article Snippet: The sections were then incubated overnight at 4 °C with primary antibodies, CCT5 (11603- 1-AP, Proteintech).

Techniques: Cell Cycle Assay

Fig. 5 CCT5 expression is correlated with cancer stemness. (A) CCT5 expression and mRNAsi. (B) CCT5 expression with mDNAsi. (C–H) CCT5 expression levels and CytoTRACE scores in primary liver cancer (C–D), READ (E–F) and BRCA (G–H)

Journal: Cancer immunology, immunotherapy : CII

Article Title: Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.

doi: 10.1007/s00262-025-04071-7

Figure Lengend Snippet: Fig. 5 CCT5 expression is correlated with cancer stemness. (A) CCT5 expression and mRNAsi. (B) CCT5 expression with mDNAsi. (C–H) CCT5 expression levels and CytoTRACE scores in primary liver cancer (C–D), READ (E–F) and BRCA (G–H)

Article Snippet: The sections were then incubated overnight at 4 °C with primary antibodies, CCT5 (11603- 1-AP, Proteintech).

Techniques: Expressing

Fig. 7 Flow charts of the machine learning process. (A) Selection of CCT5.Sig genes. (B) Datasets integration and machine learning process

Journal: Cancer immunology, immunotherapy : CII

Article Title: Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.

doi: 10.1007/s00262-025-04071-7

Figure Lengend Snippet: Fig. 7 Flow charts of the machine learning process. (A) Selection of CCT5.Sig genes. (B) Datasets integration and machine learning process

Article Snippet: The sections were then incubated overnight at 4 °C with primary antibodies, CCT5 (11603- 1-AP, Proteintech).

Techniques: Selection